ribavirin has been researched along with Severe Fever with Thrombocytopenia Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, C; Li, J; Li, L; Li, X; Sun, S; Xia, G; Zhang, Z; Zhou, S; Zou, G | 1 |
| Huang, Y; Miao, W; Xu, Y; Zhang, Y | 1 |
2 other study(ies) available for ribavirin and Severe Fever with Thrombocytopenia Syndrome
| Article | Year |
|---|---|
A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study.
Topics: C-Reactive Protein; Humans; Phlebovirus; Retrospective Studies; Ribavirin; Severe Fever with Thrombocytopenia Syndrome; Thrombocytopenia | 2023 |
Severe fever with thrombocytopenia syndrome in Hefei: Clinical features, risk factors, and ribavirin therapeutic efficacy.
Topics: Adult; Aged; Antiviral Agents; China; Female; Humans; Male; Middle Aged; Phlebovirus; Ribavirin; Risk Factors; Severe Fever with Thrombocytopenia Syndrome; Treatment Outcome | 2021 |